Where does Myrtelle's cap table come from?

Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Myrtelle's 4 recorded funding rounds.

Premier Alternatives

Myrtelle

New York, NY · Founded 2020 · Privately Held (backing)

Operator of a gene therapy company intended to offer innovative clinical trials for the treatment of the rare monogenic disorder. Myrtelle is based in New York, NY and was founded in 2020. Its last reported valuation was $134 million in Dec 2022. It has raised $82.6 million across 4 recorded rounds; the latest was a $30.5 million early-stage round in Dec 2025.

Last reported valuation

$134.0M

Oct 2026

Priced at

—

Total raised

$82.6M

Last round

Early Stage VC

Dec 2025

Cap table — not yet on record

Myrtelle's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.

Free account

More of Myrtelle with a free account

·Watch Myrtelle: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Frequently asked about Myrtelle

Where does Myrtelle's cap table come from?: Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Myrtelle's 4 recorded funding rounds.